Stevastelin A
Alternative Names: NK 374186ALatest Information Update: 16 Aug 2007
At a glance
- Originator Nippon Kayaku
- Class Depsipeptides
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Immunological disorders; Transplant rejection
Most Recent Events
- 06 Aug 1998 No-Development-Reported for Immunological disorders in Japan (unspecified route)
- 06 Aug 1998 No-Development-Reported for Transplant rejection in Japan (unspecified route)
- 10 Jan 1996 Preclinical development for Immunological disorders in Japan (unspecified route)